NYMC Faculty Publications
Arrhythmogenesis and COVID-19
Author Type(s)
Faculty
DOI
10.1097/CRD.0000000000000407
Journal Title
Cardiology in Review
First Page
289
Last Page
291
Document Type
Review Article
Publication Date
11-2021
Department
Medicine
Keywords
Anti-Bacterial Agents, Antirheumatic Agents, Arrhythmias, Cardiac, Azithromycin, COVID-19, Humans, Hydroxychloroquine, Intensive Care Units, SARS-CoV-2, Severity of Illness Index, COVID-19 Drug Treatment
Disciplines
Medicine and Health Sciences
Abstract
The ongoing coronavirus infection-2019 (COVID-19) global pandemic has had devastating impacts on the global population since 2019. Cardiac complications are a well-documented sequala of COVID-19, with exposed patients experiencing complications such as myocardial infarction, myocarditis, and arrythmias. This article aims to review prominent literature regarding COVID-19 and its link with arrhythmias, as well as to discuss some of the possible mechanisms by which arrhythmogenesis may occur in patients with COVID-19.
Recommended Citation
Varkey, J. N., & Frishman, W. H. (2021). Arrhythmogenesis and COVID-19. Cardiology in Review, 29 (6), 289-291. https://doi.org/10.1097/CRD.0000000000000407
